| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q3 2015 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GREEN PLAINS INC | 12 | Q3 2023 | 6.5% |
| XERIS PHARMACEUTICALS INC | 12 | Q3 2023 | 0.3% |
| ACORDA THERAPEUTICS INC | 11 | Q3 2023 | 1.0% |
| TEAM INC | 11 | Q2 2023 | 0.9% |
| CHESAPEAKE ENERGY CORP | 11 | Q3 2023 | 0.5% |
| ISHARES TR | 10 | Q3 2023 | 49.6% |
| GREEN PLAINS INC | 10 | Q3 2023 | 8.8% |
| GREEN PLAINS INC | 9 | Q3 2023 | 6.2% |
| NABORS INDS INC NEW | 9 | Q2 2023 | 2.0% |
| TRAVERE THERAPEUTICS INC | 8 | Q3 2022 | 1.4% |
View Saltoro Capital, LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-10 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR/A | 2022-08-17 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-12 |
| 13F-HR/A | 2022-02-09 |
View Saltoro Capital, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.